List of Excipients in Branded Drug IBUPROFEN MINIS

Generic Drugs Containing IBUPROFEN MINIS

Company	Ingredient	NDC	Excipient
Walgreens	ibuprofen	0363-0743	FD&C GREEN NO. 3
Walgreens	ibuprofen	0363-0743	GELATIN
Walgreens	ibuprofen	0363-0743	MEDIUM-CHAIN TRIGLYCERIDES
Walgreens	ibuprofen	0363-0743	POLYETHYLENE GLYCOL

What are the Most Frequently-Used Excipients in IBUPROFEN MINIS?

# Of NDCs	Excipient
20	FD&C GREEN NO. 3
20	GELATIN
1	LECITHIN, SOYBEAN
18	MEDIUM-CHAIN TRIGLYCERIDES

Excipient Strategy and Commercial Opportunities for Ibuprofen Minis

Last updated: March 1, 2026

What is the excipient strategy for Ibuprofen Minis?

Ibuprofen Minis are low-dose, small-sized formulations designed for rapid absorption and ease of swallowing, frequently targeted at pediatric and geriatric populations. The excipient strategy focuses on optimizing bioavailability, stability, and patient compliance.

Core excipients used in Ibuprofen Minis:

• Fillers and bulking agents: Microcrystalline cellulose and pregelatinized starch provide volume and aid compression.
• Binders: Povidone (PVP) enhances tablet cohesion.
• Disintegrants: Crospovidone, croscarmellose sodium, and sodium starch glycolate enable rapid tablet breakup.
• Lubricants: Magnesium stearate ensures smooth manufacturing.
• Glidants: Colloidal silica improves powder flowability.
• Coatings: Film coatings composed of hydroxypropyl methylcellulose (HPMC) and titanium dioxide control moisture and mask taste.

Key considerations:

• Taste masking: Use of flavoring agents and sweeteners like sucralose or aspartame.
• Rapid disintegration: Use of superdisintegrants to meet fast-acting therapeutic needs.
• Stability: Selection of excipients resistant to moisture and light, extending shelf life.
• Patient acceptability: Smaller size, palatable taste, and easy swallowing.

What are the commercial opportunities for Ibuprofen Minis?

Market size and growth predictors:

• Market valuation: The global OTC ibuprofen market reached $8.5 billion in 2022.
• Projected CAGR: 4-5% through 2030, driven by demand for pediatric and geriatric formulations.
• Segment potential: Minis formulations account for approximately 15% of total OTC ibuprofen sales, with room to expand due to consumer preference for convenient formats.

Competitive landscape:

• Brand dominance: Major brands include Advil, Motrin, and Nurofen, with market share led by established OTC formulations.
• Innovative products: Companies investing in minis formats, dissolvable tablets, and liquid gels.

Licensing and partnerships:

• Opportunities: Intellectual property licensing for existing formulations.
• Strategic alliances: Co-development with consumer health companies to expand distribution.

Regulatory factors:

• Approvals: US FDA OTC monograph for ibuprofen; EMA approval processes complement market access.
• Labeling: Emphasis on pediatric and geriatric indications.

Manufacturing and distribution:

• Focus on scalable, cost-efficient production processes for small tablets.
• Distribution channels include pharmacies, supermarkets, and online retail.

Strategic recommendations

• Incorporate taste-masking excipients aligned with regulatory standards.
• Develop formulations with fast disintegration to meet consumer demand for immediate relief.
• Leverage growing demand in pediatric and geriatric segments.
• Secure patents on specific minis excipient configurations to protect market position.
• Focus on sustainable excipient sourcing to appeal to environmentally conscious consumers.

Summary table: Excipient functions in Ibuprofen Minis

Excipient Type	Function	Example
Fillers and bulking agents	Provide volume, facilitate compression	Microcrystalline cellulose
Binders	Hold tablet components together	Povidone (PVP)
Disintegrants	Enable rapid tablet breakup	Crospovidone
Lubricants	Ensure ease of manufacture	Magnesium stearate
Glidants	Improve flow properties of powder	Colloidal silica
Coatings	Protect, mask taste, functionalize release	HPMC, titanium dioxide

Key Takeaways

• Excipients in Ibuprofen Minis prioritize rapid disintegration, taste masking, and stability, aligning with consumer preferences and regulatory standards.
• Market growth is driven by demand within pediatric and geriatric segments, with minis formats taking an increasing share.
• Strategic positioning involves securing patents, optimizing manufacturing processes, and leveraging licensing partnerships.
• Regulatory compliance and sustainable sourcing remain safety and brand reputation pillars.

FAQs

1. What excipient adjustments are needed for pediatric Ibuprofen Minis?
   Use gentle binders, sweeteners like sucralose, and flavoring agents to improve palatability, alongside rapid disintegrants for quick relief.

2. Can excipient choice influence regulatory approval?
   Yes. Regulatory bodies scrutinize excipient safety, stability, and labeling. Excipients must meet pharmacopeial standards and undergo safety assessments.

3. What are the main cost considerations in formulating Minis?
   Excipients like disintegrants and coatings influence raw material costs, while manufacturing small tablets requires precise equipment to ensure uniformity.

4. How does excipient selection affect shelf life?
   Moisture-resistant excipients and stable film coatings extend product shelf life, essential for international distribution.

5. What emerging excipient trends impact Minis formulations?
   Use of eco-friendly excipients, alternative disintegrants, and biocompatible coating materials aligns with sustainability goals and consumer expectations.

---

References

[1] Market Research Future. (2022). Over-the-counter (OTC) Ibuprofen Market Analysis.
[2] United States Food and Drug Administration. (2022). OTC Drug Review – Ibuprofen.
[3] European Medicines Agency. (2022). Guideline on formulations for paediatric use.